Дискусије : Здравље

 Коментар
Za dr. Galeba-Cesta povreda rebara
langehare
(glumica)
04. август 2009. у 18.43
Dragi doktore,
vidim da nesebično pomazete ljudima, pa rekoh, da vas i ja upitam za jedan savet. Odnedavno sam primetila nešto neobično sto mi se desava. Već četvrti put u nekoliko meseci povredim, tacnije receno, nagnjecim rebra, a da pri tom nisam izlozena nekom naročitom pritisku. Npr. jednom prilikom sin me zagrlio i malo jače stisnuo uz sebe, i tom prilikom lepo se čulo ono „kvrc” i osetila sam ostar bol i narednih 10-ak dana sam pri svakom pokretu osecala strasan bol, čak i pri disanju. Mislila sam da je ipak on bio malo pregrub, ali sledeći put sam sa prednjeg sedista u autu pokusala da dohvatim jaknu koja je lezala na zadnjem sedistu i tom prilikom sam malo jače nalegla na rub mog sedista i ponovo se desilo isto samo na drugoj strani prsnog kosa. Danas sam pokusala da dohvatim nešto sa poda i nagela sam se preko fotelje i opet „kvrc” i evo me, ne znam da li ću ujutro biti u stanju sama da se obucem. Nisam do sada isla doktoru misleci da su to glupe povredice, ali obzirom da mi se to pocesto desava pocela sam i da se brinem da nešto ipak nije u redu. Vas pitam: da li imam razlog za zabrinutost, može li to biti pokazatelj nečeg ozbiljnijeg i treba li da tražim od kucnog doktora neke ciljane preglede? Samo da napomenem da imam 53 godine, dobrog sam zdravlja i normalne tezine. Unapred vam se mnogo zahvaljujem na odgovoru i srdacan pozdrav iz Nemacke.
Galeb
06. август 2009. у 17.20
Teško bi biulo reci bez pregleda o cemu bi se moglo raditi. Problemi mogu dolaziti od misica, zivaca, ali i od kicme. Ne mislim da se radi o necem ozbiljnom jer se ppjavljujei nestaje. Za svaki slučaj bilo bi dobro da se javite na pregled kod svog porodicnog ljekara koji će zasigurno moći izdiferencirati o cemu je stvar i uputiti vas nadleznom specijalisti (Fizijatru, Neurologu).
Sve najbolje Galeb.
volens_nolens
(.)
06. август 2009. у 22.05
Vi ste textbook slučaj Osteoporoze(53god+menopauza),odmah treba da posjetite doktora,radi se o tome da su rebra jedna od tanjih kostiju u nasem organizmu,i velika je vjerovatnoca da su vam rebra prsla iz tog rasloga.Inače se desava da pacijent slomi kuk,clanak, ili lakat sto dovodi do komplikacija mobilnosti i sl.
Napravite rentgen snimak rebara i mislim da ima test gdje vam se može utvrditi „bone density”(punoca ili poroznost kostiju)Uradite ovo sto prije i pazite se padova je mogu biti fatalni.

volens_nolens
(.)
06. август 2009. у 22.10
http://tinyurl.com/m6tobh
Vise na njemackom ovdje.
volens_nolens
(.)
06. август 2009. у 22.14
Na zalost Google translate ne dozvoljava link.
Ukucajte u Google-u Bone Density Test Osteoporosis iskopirajete adresu u prozorcetu(http:/www.ljlkj.com primjer) otidjite onda na Google translate i stavite tamo iskopiranu adresu i odaberite da prevede(translate) English to German kompletnu web stranicu.
langehare
(glumica)
07. август 2009. у 11.31
Mnogo vam hvala oboma na javljanju. Linkove sam procitala i sledeće sedmice idem odmah doktoru. Sto je sigurno, sigurno je...
Nokia1974
08. септембар 2009. у 14.08
Šta god da ste odlucili samo nemojte da uzimate ovaj lijek Fosamax.

Posted on Fri, Sep. 04, 2009
Fosamax case first of many against Merck
By Natasha Singer New York Times News Service Drug executives, product liability lawyers and Wall Street analysts are closely watching a jury trial in New York over medical problems associated with Fosamax, a drug from Merck that has been taken by millions of women to offset bone loss associated with menopause. It is the first of about 900 state and federal cases pending against Merck in which plaintiffs claim that taking Fosamax caused them to develop a rare problem called osteonecrosis of the jaw. Dental surgery is one of the triggers for the condition that can break down jawbone tissue, causing the gums to fall away and expose bone that looks moth-eaten, oral surgeons said. In the first case against Merck, which began last month in a United States District Court in Manhattan, Shirley Boles, a 71-year-old retired deputy sheriff from Fort Walton Beach, Fla., alleges that taking Fosamax from 1997 to 2006 caused her jawbone tissue to die. The problem developed after she had tooth extraction in 2002, leaving her with ongoing medical problems that include infections that drain through open wounds in her chin. United States District Judge John F. Keenan is presiding over this case and several hundred other lawsuits from many districts, consolidated in New York to establish common issues in the litigation. A jury of three men and five women began deliberating the case on Wednesday afternoon. Compared with other drug product liability cases that have involved many thousands of plaintiffs, the Fosamax litigation is relatively small. But because Merck is trying to complete a $41 billion merger with Schering-Plough, industry analysts are closely watching this first trial to gauge Merck's potential financial liability. Merck spent $7 million in the second quarter of this year on legal expenses in the case and has set aside $42 million to defend itself in about 900 federal and state Fosamax cases brought by about 1,280 plaintiff groups, according to a company regulatory filing at the end of June. Meanwhile, other drug companies and plaintiffs' lawyers expecting to try similar cases involving related bone drugs have been closely monitoring the case to see which arguments resonate with the jury.
Merck's main defense is that there is no definitive medical evidence proving that Fosamax causes jawbone death and that Boles had other health factors that could have caused her jaw problems. Meanwhile, Timothy O'Brien, lead lawyer for Boles, has been using the case to put Fosamax itself on trial, contending that Merck as a corporation put patients at risk by overpromoting Fosamax and by not warning doctors who prescribe the drug about the potential for jawbone disintegration. The trial began Aug. 12. O'Brien has presented internal Merck e-mail messages, company documents and case reports from medical journals to bolster his case that Merck knew about jaw problems associated with Fosamax and did not study the problem or warn doctors about it in a timely fashion. Merck contends that the company became aware of the problem only in late 2003 after the first case report associating bisphosphonates with jaw injuries appeared in a medical journal. According to evidence in the case, the company subsequently assembled a panel of doctors to review reports it had received and determine which cases were likely to be osteonecrosis of the jaw. The Food and Drug Administration approved Fosamax in 1995 to treat the bone loss of osteoporosis associated with menopause. In 1997, the agency approved the drug to prevent osteoporosis itself. Until the recent introduction of branded and generic competitors for the osteoporosis drug market, Fosamax was one of the most popular drugs in the United States. Doctors in the United States wrote about 2.6 million prescriptions for the drug last year, which was down from more than 15 million prescriptions in 2007, according to annual reports from Drug Topics, an industry magazine.
© 2009 Kentucky.com and wire service sources. All Rights Reserved.
http://www.kentucky.com
 Коментар Запамти ову тему!

Looking for Oil Diffuser Necklaces Sterling Silver?
.